Alnylam Pharmaceuticals, Inc. (ALNY)
252.98
+5.47
(+2.21%)
USD |
NASDAQ |
Sep 11, 12:56
Alnylam Pharmaceuticals Gross Profit (TTM) : 3.827B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.827B |
| March 31, 2026 | 3.465B |
| December 31, 2025 | 3.032B |
| September 30, 2025 | 2.693B |
| June 30, 2025 | 2.059B |
| March 31, 2025 | 2.020B |
| December 31, 2024 | 1.925B |
| September 30, 2024 | 1.788B |
| June 30, 2024 | 2.040B |
| March 31, 2024 | 1.682B |
| December 31, 2023 | 1.518B |
| September 30, 2023 | 1.448B |
| June 30, 2023 | 1.005B |
| March 31, 2023 | 955.39M |
| December 31, 2022 | 868.60M |
| September 30, 2022 | 805.70M |
| June 30, 2022 | 737.48M |
| March 31, 2022 | 735.27M |
| December 31, 2021 | 704.14M |
| September 30, 2021 | 623.81M |
| June 30, 2021 | 572.90M |
| March 31, 2021 | 475.13M |
| December 31, 2020 | 414.80M |
| September 30, 2020 | 333.77M |
| June 30, 2020 | 294.56M |
| Date | Value |
|---|---|
| March 31, 2020 | 241.17M |
| December 31, 2019 | 172.73M |
| September 30, 2019 | 132.60M |
| June 30, 2019 | 66.43M |
| March 31, 2019 | 35.79M |
| December 31, 2018 | 18.05M |
| September 30, 2018 | 32.90M |
| June 30, 2018 | 34.21M |
| March 31, 2018 | 34.21M |
| December 31, 2017 | 34.21M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | 835.84M |
| BridgeBio Pharma, Inc. | 671.14M |
| Regeneron Pharmaceuticals, Inc. | 12.65B |
| Vertex Pharmaceuticals, Inc. | 10.94B |
| Pfizer Inc. | 41.30B |